Publications

Detailed Information

How to overcome diabetic retinopathy: Focusing on blood-retinal barrier

Cited 0 time in Web of Science Cited 8 time in Scopus
Authors

Jo, D.H.; Kim, J.H.; Kim, J.H.

Issue Date
2012
Publisher
Bentham Science Publishers
Citation
Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, Vol.12 No.2, pp.110-117
Abstract
Diabetic retinopathy (DR) is one of the common microvascular complications of diabetes, resulting in visual deterioration in working populations. Even in the early stage of DR, increased permeability can occur and is known to be associated with the disruption of the blood-retinal barrier (BRB). In this regard, studies on the pathogenesis of DR have been focused on the alteration of the BRB, however, detailed and unifying mechanisms and pathogenesis-based treatment of DR are yet to be elucidated. In this review, we discussed the pathogenesis of DR associated with the disruption of the BRB and reviewed novel therapeutic options. We expect that this review will help to form a consensus for pathogenesis-based treatments of DR in consideration with the disruption of the BRB. © 2012 Bentham Science Publishers.
ISSN
1871-5222
URI
https://hdl.handle.net/10371/191641
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Related Researcher

  • College of Medicine
  • Department of Medicine
Research Area

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share